Podcast: The AI Revolution: From Autism to Empathy with Sharief Taraman, MD

In this episode, we dive into the fascinating intersection of artificial intelligence and pediatric neurology. Dr. Taraman shares how he became interested in AI's role in healthcare and discusses how AI is being utilized to enhance diagnostic accuracy, especially in neurodevelopmental pediatrics. We explore how these advancements are improving access to care in resource-limited settings and the impact of early diagnosis on long-term outcomes for conditions like autism.
Join us as we uncover the latest technological innovations transforming pediatric healthcare, the potential of AI to personalize treatment plans for children, and the concerns surrounding the widespread use of AI in medicine.
Dr. Sharief Taraman, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine.
Dr. Taraman was the former Division Chief of Pediatric Neurology at Children’s Health of Orange County and University of California-Irvine. He remains an active member of the medical staff and the Sharon Disney Lund Medical Intelligence, Information, Investigation, & Innovation Institute at CHOC.
He is a Health Sciences Associate Clinical Professor at UC Irvine School of Medicine in the Department of Pediatrics and Affiliate Professor at Chapman University, Dale E. and Sarah Ann Fowler School of Engineering.
Dr. Taraman is active in the community as the past president of the American Academy of Pediatrics (AAP) Orange County Chapter, board member of AAP-California, and committee member for the development of the AAP National CHILD health registry. He also serves on the Irvine Unified School District Medical Advisory Board, volunteers for the Capistrano Unified School District and with Girl Scouts of Orange County.
Recognized globally as an innovator and specifically an advocate in the field of pediatrics, Dr. Taraman has been involved with the development of three FDA designated breakthrough devices, awardee of the prestigious National Capital Consortium for Pediatric Device Innovation grant, and is an advisor to Board of Directors for the International Society for Pediatric Innovation.
He is the Chief Executive Officer at Cognoa and formerly served as the Chief Medical Officer leading the clinical trials that led to the FDA authorization of Cognoa’s lead product, Canvas Dx, the first and only FDA authorized diagnostic device for autism for children 18-72 months old with concern for developmental delay.
Dr. Taraman graduated Magna Cum Laude from the University of Michigan having majored in Biochemistry. He completed his medical education at Wayne State University School of Medicine and went on to complete residency and fellowship training in Pediatrics and Pediatric Neurology at the Detroit Medical Center and Children’s Hospital of Michigan. He continued professional development through the University of California, Irvine - The Paul Merage School of Business with certifications in Leadership for Healthcare Transformation & Physician Leadership.
cognoa.com/
This week's episode is sponsored by Toveedo! The Jewish videos your kids love, all in one happy place. Use code JOWMA10 for $10 off at ⁠⁠⁠⁠toveedo.com/⁠⁠⁠⁠!
_________________________________________________
• Sponsor the JOWMA Podcast! Email [e-mail]
• Become a JOWMA Member! www.jowma.org
• Follow us on Instagram! JOWMA_org
• Follow us on Twitter! JOWMA_med
• Follow us on Facebook! / jowmaorg
• Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! jowma.us6.list...